Search results for "Fallopia"

showing 10 items of 28 documents

Arable-weed flora and its pollen representation: A case study from the eastern part of France

2007

International audience; Local pollen deposition in human-influenced vegetation types is studied with the aim of establishing the relationship between arable-weed vegetation and its pollen representation as an aid in interpreting human presence and impact on vegetation from pollen assemblages. The study area is located in the Franche-Comté region, eastern part of France. The presence of plants within 100 m2 plots and their pollen representation in moss samples within the same plots was recorded from different crops and annual fallows. Patterns in the vegetation and pollen assemblages were investigated separately using principal coordinate analysis (PCoA). Procrustean co-inertia analysis (PCI…

0106 biological sciences010506 paleontologyPollination[SDV]Life Sciences [q-bio]ScleranthusPOLLEN-VEGETATION RELATIONSHIPSpollen–vegetation relationshipsmedicine.disease_cause010603 evolutionary biology01 natural sciencesPollenBotanymedicineEcology Evolution Behavior and Systematics0105 earth and related environmental sciencesbiologyEcologyPaleontologyVegetation15. Life on landbiology.organism_classificationFallopia[SDE.ES]Environmental Sciences/Environmental and Societymodern pollenanthropogenic indicatorsarable weedsTaxonprocrustean analyses[SDE]Environmental SciencesBiological dispersal[SDE.ES] Environmental Sciences/Environmental and SocietyFranceCentaurea cyanus[ SDE.ES ] Environmental Sciences/Environmental and Society
researchProduct

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial.

2017

Abstract Purpose The prognosis is poor for patients with recurrent, platinum-resistant epithelial ovarian cancer (EOC). Evidence suggests that antiangiogenic treatment modalities could play a major role in EOC. A combined therapy consisting of the investigational oral antiangiogenic agent pazopanib and metronomic oral cyclophosphamide may offer a well-tolerable treatment option to patients with recurrent, previously treated EOC. Patients and methods This study was designed as a multicenter phase I trial evaluating the optimal dose as well as activity and tolerability of pazopanib with metronomic cyclophosphamide in the treatment of patients with recurrent, platinum-resistant, previously tre…

0301 basic medicineOncologyDiarrheamedicine.medical_specialtyIndazolesCyclophosphamideMaximum Tolerated DosePlatinum CompoundsCarcinoma Ovarian EpithelialDisease-Free SurvivalPazopanib03 medical and health sciences0302 clinical medicineLiver Function TestsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansNeoplasms Glandular and EpithelialAdverse effectCyclophosphamideFatigueAgedOvarian NeoplasmsSulfonamidesLeukopeniabusiness.industryObstetrics and GynecologyLeukopeniaMiddle Agedmedicine.diseaseSurgeryRegimen030104 developmental biologyPyrimidinesOncologyTolerabilityDrug Resistance Neoplasm030220 oncology & carcinogenesisFallopian tube cancerFemalemedicine.symptomNeoplasm GradingNeoplasm Recurrence LocalbusinessOvarian cancerNeoplasms Cystic Mucinous and Serousmedicine.drugGynecologic oncology
researchProduct

The Association of Appendectomy, Adhesions, Tubal Pathology, and Female Infertility.

2019

Background and Objectives: The aim of the study was to investigate a potential association between previous childhood appendectomy, tube pathology, and female infertility. Methods: We reviewed patients seeking care at the fertility clinic of our university medical center between 2006 and 2016. The history of previous appendectomy was extracted from hospital documentation and by telephone follow-up. Tubal patency was assessed by diagnostic laparoscopy and chromopertubation. Results: In our study cohort (N = 237), 24.9% (n = 59) had a history of previous appendectomy. Previous appendectomy, therefore, was about 3-fold more prevalent in women seeking fertility treatment than in the general pop…

Adult050101 languages & linguisticsmedicine.medical_specialtymedia_common.quotation_subjectAdhesionsPopulationFertilityDiagnostic laparoscopyTissue AdhesionsScientific Paper050105 experimental psychologyCohort StudiesmedicineAppendectomyHumans0501 psychology and cognitive sciencesUniversity medicalFemale infertilityeducationmedia_commonRetrospective Studieseducation.field_of_studybusiness.industryGeneral surgery05 social sciencesFemale infertilityTubal pathologyFallopian Tube Diseasesmedicine.diseaseAppendicitisTube pathologyAppendicitisCohortSurgeryFemaleLaparoscopybusinessInfertility FemaleJSLS : Journal of the Society of Laparoendoscopic Surgeons
researchProduct

Initial experience of a new linear everting falloposcopy system in comparison with hysterosalpingography

1993

Objective To assess the endolumenal portion of the fallopian tube from ostium to fimbria using a specially designed linear everting catheter and microendoscope. The study compared falloposcopy results with those obtained with hysterosalpingography (HSG) in the same patients and explored the system's ability to classify internal tubal conditions. Design A prospective study of a new diagnostic technique, falloposcopy, versus conventional means of evaluating tubal status. Setting A tertiary university infertility center. Patients Eighteen infertile patients with a previous history of infertility of at least 2 years duration. Intervention Diagnostic falloposcopy was performed on a total of 31 t…

AdultInfertilitymedicine.medical_specialtyHysteroscopyFalloposcopyHumansMedicineProspective StudiesHysterosalpingographyFallopian TubesAnalysis of Variancemedicine.diagnostic_testbusiness.industryObstetrics and Gynecologymedicine.diseaseHysterosalpingographySurgeryEndoscopyCatheterOstiummedicine.anatomical_structureReproductive MedicineHysteroscopyFemalebusinessInfertility FemaleFallopian tubeFertility and Sterility
researchProduct

Phase 2 Trial of Docetaxel, Gemcitabine, and Oxaliplatin Combination Chemotherapy in Platinum- and Paclitaxel-Pretreated Epithelial Ovarian Cancer

2009

Background: This phase 2 trial was designed to evaluate the efficacy and toxicity of a combination of docetaxel, gemcitabine, and oxaliplatin for platinum- and paclitaxel-pretreated epithelial ovarian cancer. Patients and Methods: Heavily pretreated patients (N = 30; median age, 61 years) received docetaxel, 55 mg/m2; gemcitabine, 500 mg/m2 (day 1); and oxaliplatin, 70 mg/m2 (day 2) biweekly. Twelve patients had platinum-sensitive disease, and 18 patients had platinum-resistant disease. Results: Median follow-up was 18.6 months. No differences in patient characteristics were observed between patients with carboplatinum-sensitive and carboplatinum-resistant disease. In patients with carbopla…

AdultOncologymedicine.medical_specialtyAdolescentOrganoplatinum CompoundsPaclitaxelAnemiaDocetaxelNeutropeniaDeoxycytidineYoung Adultchemistry.chemical_compoundRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumansNeoplasm InvasivenessProspective StudiesPeritoneal NeoplasmsAgedNeoplasm StagingOvarian Neoplasmsbusiness.industryObstetrics and GynecologyCombination chemotherapyMiddle AgedPrognosismedicine.diseaseGemcitabineGemcitabineOxaliplatinOxaliplatinTreatment OutcomeOncologyDocetaxelPaclitaxelchemistryFemaleTaxoidsOvarian cancerbusinessmedicine.drugInternational Journal of Gynecological Cancer
researchProduct

Phase II trial of docetaxel and carboplatin in recurrent platinum-sensitive ovarian, peritoneal and tubal cancer

2007

Abstract Objective. Docetaxel and carboplatin are active in relapsed ovarian, peritoneal and tubal cancer. Recently, two prospective-randomized trials showed an advantage of carboplatin combination regimen with paclitaxel or gemcitabine over carboplatinum alone in platinum-sensitive cases. The question on the most effective combination with the best tolerable side effects still needs to be answered. Methods. Eligible patients had recurrent ovarian, peritoneal or tubal cancer (platinum-free interval >6 months), performance status 0–2 and normal bone marrow, renal and hepatic function. 25 patients (age 18–75 years) were enrolled into this phase II trial. Patients with debulking operation of r…

AdultOncologymedicine.medical_specialtyPopulationDocetaxelGastroenterologyDisease-Free SurvivalCarboplatinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineFallopian Tube NeoplasmsHumanseducationPeritoneal NeoplasmsAgedOvarian Neoplasmseducation.field_of_studyPerformance statusbusiness.industryObstetrics and GynecologyCancerMiddle AgedDebulkingmedicine.diseaseGemcitabineCarboplatinRegimenOncologyDocetaxelchemistryDrug Resistance NeoplasmFemaleTaxoidsNeoplasm Recurrence Localbusinessmedicine.drugGynecologic Oncology
researchProduct

Laparoscopic management of interstitial pregnancy: the "purse-string" technique

2012

We report five cases of interstitial pregnancy, treated between 2004 and 2010, to evaluate surgical and obstetric outcome of laparoscopic cornual resection with a "purse-string" technique. A hemostatic suture was passed at the base of the mass in a purse-string fashion prior to resection, to minimize intraoperative blood loss. Subsequent pregnancies were analysed, with a mean follow-up time of 48 months. The mean operating time was 39 min and mean blood loss 47 mL. Three of four patients who desired children delivered at term uneventfully. Laparoscopic cornual resection with a "purse-string" technique appears to be useful for treatment of early interstitial pregnancy. The technique ensures …

Adultpurse-string techniqueSuture TechniquesFertility PreservationGestational AgeSettore MED/40 - Ginecologia E OstetriciaLaparoscopy interstitial pregnancy purse-string technique ectopic pregnancy hemostatic suture.hemostatic sutureSettore MED/18 - Chirurgia GeneraleTreatment OutcomePregnancyinterstitial pregnancyHumansectopic pregnancyChorionic Gonadotropin beta Subunit HumanFemalePregnancy TubalLaparoscopyBiomarkersFallopian Tubes
researchProduct

Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.

1988

In an effort to overcome possible interference by endogenous gonadotropin-ovarian hormone dynamics, desensitization of the pituitary gonadotropins by a gonadotropin-releasing hormone agonist (GnRHa) was achieved in 12 women with repeatedly failed attempts at multiple follicular stimulation. Eight women were scheduled for in vitro fertilization (IVF) and embryo transfer (ET), and 4 for gamete intrafallopian transfer (GIFT). Stimulation failure was characterized by premature luteinization, poor estradiol (E2) response, or inadequate follicular growth. The agonist was administered by nasal spray 500 to 600 micrograms/day beginning on days 21 to 23 of the menstrual cycle. A rapid desensitizatio…

AgonistAdultendocrine systemmedicine.medical_specialtyMenotropinsmedicine.drug_classmedia_common.quotation_subjectmedicine.medical_treatmentFertilization in VitroBiologyBuserelinReproductive TechniquesOvulation InductionInternal medicineGonadotropin-releasing hormone agonistFollicular phasemedicineHumansGamete intrafallopian transferMenstrual cyclemedia_commonIn vitro fertilisationObstetrics and GynecologyEmbryo TransferEmbryo transferEndocrinologyReproductive MedicineFemaleMenotropinhormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Angiogenesis biomarker study of a phase II trial of pazopanib (P) in recurrent or persistent ovarian (EOC), peritoneal (PPC), or fallopian tube cance…

2012

e15575 Background: Angiogenesis is essential to tumor growth, invasion, and metastasis in EOC. The aim of this study was to identify angiogenic biomarkers to predict response to P, a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit, in a clinical phase II trial. Methods: We analyzed a series of 20 out of 25 women enrolled in a GEICO Phase II trial that studied the Clinical Benefit Rate (CBR) of P in platinum-resistant EOC, PPC and FTC (results will be presented in an additional abstract). Formalin-fixed, paraffin-embedded tumors at diagnosis were evaluated for the microvessel density (MVD) by using CD31 immunostaining…

CD31OncologyCancer Researchmedicine.medical_specialtyPathologyAngiogenesisbusiness.industrymedicine.diseaseMetastasisPazopanibOncologyInternal medicineFallopian tube cancermedicineBiomarker (medicine)ImmunohistochemistryOvarian cancerbusinessmedicine.drugJournal of Clinical Oncology
researchProduct

A comparison of cytoplasmic and nuclear estradiol and progesterone receptors in human fallopian tube and endometrial tissue

1981

Quantitative and qualitative aspects of the in vitro binding of 3 H-estradiol and 3 H-progesterone to receptor components from human endometrium and fallopian tube cytoplasmic and nuclear fractions were studied. The steroid binding macromolecules formed in vitro could be extracted from nuclei by 0.4M KCl and detected by glycerol gradient centrifugation. Both estradiol- and progesterone-binding compounds formed only one peak (under high ionic strength conditions) with a sedimentation coefficient of about 4-5S. The number of cytoplasmic and nuclear binding sites for both estradiol and R5020 varied dramatically throughout the menstrual cycle: the estradiol and progesterone receptor concentrati…

Cytoplasmmedicine.medical_specialtymedia_common.quotation_subjectmedicine.medical_treatmentBiologyPromegestoneSteroidInfundibulumEndometriumInternal medicineProgesterone receptorFollicular phasemedicineHumansTissue DistributionReceptorFallopian TubesProgesteroneMenstrual cyclemedia_commonCell NucleusEstradiolObstetrics and GynecologyMenstruationCytosolEndocrinologymedicine.anatomical_structureReceptors EstrogenReproductive MedicineFemaleReceptors Progesteronehormones hormone substitutes and hormone antagonistsFallopian tubeFertility and Sterility
researchProduct